Home/Pipeline/Tau Mislocalization Assay for AD Therapeutics

Tau Mislocalization Assay for AD Therapeutics

Alzheimer's Disease

Assay DevelopmentActive

Key Facts

Indication

Alzheimer's Disease

Phase

Assay Development

Status

Active

Company

Xona Microfluidics

About Xona Microfluidics

Xona Microfluidics is a specialized tools and services company at the intersection of microengineering and neuroscience. It commercializes the seminal 'XonaChip' platform, which enables the precise compartmentalization of neuronal cultures for studying subcellular processes, axon biology, and disease models. Beyond product sales, the company has leveraged its scientific expertise to build a contract research organization (CRO) arm and consistently secures NIH grant funding for R&D. Positioned in the Research Triangle Park ecosystem, Xona serves academic, biotech, and pharmaceutical researchers aiming to de-risk neurological drug discovery.

View full company profile

Therapeutic Areas

Alzheimer's Disease Amyotrophic Lateral Sclerosis Parkinson's Disease Neurodegenerative Diseases Neurodevelopmental Disorders

Other Alzheimer's Disease Drugs

Drug	Company	Phase	Status
NUZ-001	Neurizon Therapeutics	Preclinical	Active
ALZN002	Alzamend Neuro	Preclinical	Research
P021	Phanes Biotech	Preclinical	Active
PB43D	Phanes Biotech	Preclinical	Active
UB-311	Vaxxinity	Phase 2	Active
Lecanemab	BioArctic	Launched	Active (Commercial)
BAN2401	BioArctic	Preclinical	Active
Undisclosed Programs	johnson-and-johnson-innovative-medicine	Pipeline	Active
MK-6240 (florquinitau)	Lantheus Medical Imaging	Regulatory Filing	Filed
NAV-4694 (flutafuranol)	Lantheus Medical Imaging	Phase 3	Active
LNTH-2620/PI-2620	Lantheus Medical Imaging	Phase 3	Recruiting
itMSCs	Stemedica Cell Technologies	Clinical Development	Active